Skip to main content


Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Fig. 2 | Journal of Neuroinflammation

Fig. 2

From: Hyperammonemia induces glial activation, neuroinflammation and alters neurotransmitter receptors in hippocampus, impairing spatial learning: reversal by sulforaphane

Fig. 2

Sulforaphane treatment does not affect body weight. The body weight at 2, 3, 4, and 6 weeks of ammonium diet are shown for control (C) and hyperammonemic (HA) rats treated with vehicle (V) or sulforaphane (SFN). Values are the mean ± SEM of 7 rats per group. Values significantly different from control rats are indicated by asterisks. **p < 0.01, ***p < 0.001

Back to article page